vs

Side-by-side financial comparison of DUCOMMUN INC (DCO) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

DUCOMMUN INC is the larger business by last-quarter revenue ($215.8M vs $197.9M, roughly 1.1× REPLIGEN CORP). REPLIGEN CORP runs the higher net margin — 6.7% vs 3.4%, a 3.3% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 9.4%). REPLIGEN CORP produced more free cash flow last quarter ($17.6M vs $-78.8M). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 6.3%).

Ducommun Inc. is a global aerospace and defense manufacturing enterprise that provides complex structural components, electronic systems and professional engineering services. It mainly serves clients across the commercial aviation, military defense and space sectors, delivering high-reliability solutions for critical aerospace application scenarios.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

DCO vs RGEN — Head-to-Head

Bigger by revenue
DCO
DCO
1.1× larger
DCO
$215.8M
$197.9M
RGEN
Growing faster (revenue YoY)
RGEN
RGEN
+4.3% gap
RGEN
13.6%
9.4%
DCO
Higher net margin
RGEN
RGEN
3.3% more per $
RGEN
6.7%
3.4%
DCO
More free cash flow
RGEN
RGEN
$96.3M more FCF
RGEN
$17.6M
$-78.8M
DCO
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
6.3%
DCO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DCO
DCO
RGEN
RGEN
Revenue
$215.8M
$197.9M
Net Profit
$7.4M
$13.3M
Gross Margin
27.7%
52.5%
Operating Margin
6.5%
9.0%
Net Margin
3.4%
6.7%
Revenue YoY
9.4%
13.6%
Net Profit YoY
9.9%
143.9%
EPS (diluted)
$0.52
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DCO
DCO
RGEN
RGEN
Q4 25
$215.8M
$197.9M
Q3 25
$212.6M
$188.8M
Q2 25
$202.3M
$182.4M
Q1 25
$194.1M
$169.2M
Q4 24
$197.3M
$174.1M
Q3 24
$201.4M
$154.9M
Q2 24
$197.0M
$154.1M
Q1 24
$190.8M
$151.3M
Net Profit
DCO
DCO
RGEN
RGEN
Q4 25
$7.4M
$13.3M
Q3 25
$-64.4M
$14.9M
Q2 25
$12.6M
$14.9M
Q1 25
$10.5M
$5.8M
Q4 24
$6.8M
$-30.3M
Q3 24
$10.1M
$-654.0K
Q2 24
$7.7M
$3.3M
Q1 24
$6.8M
$2.1M
Gross Margin
DCO
DCO
RGEN
RGEN
Q4 25
27.7%
52.5%
Q3 25
26.6%
53.2%
Q2 25
26.6%
50.0%
Q1 25
26.6%
53.6%
Q4 24
23.5%
26.1%
Q3 24
26.2%
50.0%
Q2 24
26.0%
49.8%
Q1 24
24.6%
49.5%
Operating Margin
DCO
DCO
RGEN
RGEN
Q4 25
6.5%
9.0%
Q3 25
-37.7%
8.9%
Q2 25
8.5%
7.6%
Q1 25
8.5%
3.9%
Q4 24
5.3%
-17.7%
Q3 24
7.6%
-5.1%
Q2 24
7.1%
1.0%
Q1 24
6.6%
1.3%
Net Margin
DCO
DCO
RGEN
RGEN
Q4 25
3.4%
6.7%
Q3 25
-30.3%
7.9%
Q2 25
6.2%
8.2%
Q1 25
5.4%
3.4%
Q4 24
3.4%
-17.4%
Q3 24
5.0%
-0.4%
Q2 24
3.9%
2.2%
Q1 24
3.6%
1.4%
EPS (diluted)
DCO
DCO
RGEN
RGEN
Q4 25
$0.52
$0.24
Q3 25
$-4.30
$0.26
Q2 25
$0.82
$0.26
Q1 25
$0.69
$0.10
Q4 24
$0.45
$-0.55
Q3 24
$0.67
$-0.01
Q2 24
$0.52
$0.06
Q1 24
$0.46
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DCO
DCO
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$45.3M
$767.6M
Total DebtLower is stronger
$298.8M
$542.2M
Stockholders' EquityBook value
$662.1M
$2.1B
Total Assets
$1.2B
$2.9B
Debt / EquityLower = less leverage
0.45×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DCO
DCO
RGEN
RGEN
Q4 25
$45.3M
$767.6M
Q3 25
$50.9M
$748.7M
Q2 25
$37.1M
$708.9M
Q1 25
$30.7M
$697.2M
Q4 24
$37.1M
$757.4M
Q3 24
$37.3M
$784.0M
Q2 24
$29.4M
$809.1M
Q1 24
$32.1M
$780.6M
Total Debt
DCO
DCO
RGEN
RGEN
Q4 25
$298.8M
$542.2M
Q3 25
$215.0M
$537.9M
Q2 25
$218.1M
Q1 25
$229.9M
Q4 24
$229.8M
$525.6M
Q3 24
$246.0M
Q2 24
$250.9M
Q1 24
$253.9M
Stockholders' Equity
DCO
DCO
RGEN
RGEN
Q4 25
$662.1M
$2.1B
Q3 25
$649.0M
$2.1B
Q2 25
$707.8M
$2.1B
Q1 25
$693.0M
$2.0B
Q4 24
$682.5M
$2.0B
Q3 24
$665.6M
$2.0B
Q2 24
$655.9M
$2.0B
Q1 24
$645.5M
$2.0B
Total Assets
DCO
DCO
RGEN
RGEN
Q4 25
$1.2B
$2.9B
Q3 25
$1.2B
$2.9B
Q2 25
$1.1B
$2.9B
Q1 25
$1.1B
$2.9B
Q4 24
$1.1B
$2.8B
Q3 24
$1.1B
$2.8B
Q2 24
$1.1B
$2.9B
Q1 24
$1.1B
$2.8B
Debt / Equity
DCO
DCO
RGEN
RGEN
Q4 25
0.45×
0.26×
Q3 25
0.33×
0.26×
Q2 25
0.31×
Q1 25
0.33×
Q4 24
0.34×
0.27×
Q3 24
0.37×
Q2 24
0.38×
Q1 24
0.39×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DCO
DCO
RGEN
RGEN
Operating Cash FlowLast quarter
$-74.7M
$25.7M
Free Cash FlowOCF − Capex
$-78.8M
$17.6M
FCF MarginFCF / Revenue
-36.5%
8.9%
Capex IntensityCapex / Revenue
1.9%
4.1%
Cash ConversionOCF / Net Profit
-10.03×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$-48.6M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DCO
DCO
RGEN
RGEN
Q4 25
$-74.7M
$25.7M
Q3 25
$18.1M
$48.1M
Q2 25
$22.4M
$28.6M
Q1 25
$771.0K
$15.0M
Q4 24
$18.4M
$39.2M
Q3 24
$13.9M
$49.3M
Q2 24
$3.5M
$42.2M
Q1 24
$-1.6M
$44.7M
Free Cash Flow
DCO
DCO
RGEN
RGEN
Q4 25
$-78.8M
$17.6M
Q3 25
$16.0M
$43.4M
Q2 25
$18.1M
$21.5M
Q1 25
$-4.0M
$11.4M
Q4 24
$14.6M
$33.6M
Q3 24
$12.0M
$42.3M
Q2 24
$144.0K
$37.4M
Q1 24
$-6.6M
$36.4M
FCF Margin
DCO
DCO
RGEN
RGEN
Q4 25
-36.5%
8.9%
Q3 25
7.5%
23.0%
Q2 25
9.0%
11.8%
Q1 25
-2.1%
6.8%
Q4 24
7.4%
19.3%
Q3 24
5.9%
27.3%
Q2 24
0.1%
24.3%
Q1 24
-3.5%
24.0%
Capex Intensity
DCO
DCO
RGEN
RGEN
Q4 25
1.9%
4.1%
Q3 25
1.0%
2.5%
Q2 25
2.1%
3.9%
Q1 25
2.5%
2.1%
Q4 24
2.0%
3.2%
Q3 24
1.0%
4.5%
Q2 24
1.7%
3.1%
Q1 24
2.6%
5.5%
Cash Conversion
DCO
DCO
RGEN
RGEN
Q4 25
-10.03×
1.93×
Q3 25
3.23×
Q2 25
1.79×
1.92×
Q1 25
0.07×
2.57×
Q4 24
2.72×
Q3 24
1.37×
Q2 24
0.45×
12.70×
Q1 24
-0.24×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DCO
DCO

Other$90.1M42%
Militaryand Space$60.0M28%
Electronic Systems Segment$31.3M15%
Commercial Aerospace$24.8M11%
Estimate At Completion Adjustment$6.6M3%
Industrial$3.0M1%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons